SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-012905
Filing Date
2024-03-13
Accepted
2024-03-13 06:02:05
Documents
16
Period of Report
2024-03-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20023955_8k.htm   iXBRL 8-K 27324
2 EXHIBIT 99.1 ef20023955_ex99-1.htm EX-99.1 22006
6 image00001.jpg GRAPHIC 247028
  Complete submission text file 0001140361-24-012905.txt   530366

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20240313.xsd EX-101.SCH 3871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20240313_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20240313_pre.xml EX-101.PRE 16048
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20023955_8k_htm.xml XML 4076
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 24744494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)